Bisphosphonates and Beyond: Managing Bone Density and Reducing Breast Cancer
December 10, 2009
December 10, 2009
SAN ANTONIO, Dec. 10 -- The American Association for Cancer Research issued the following news release:
Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggest that these agents may play a role in reducing recurrent breast cancer as well.
Theresa Guise, M.D., professor of medicine and Jerry W. and Peg S. Throgmartin professor of oncology in the Division of Endocrinology at the Indiana University School of Medicine, will m . . .
Bisphosphonates are routinely given to women with postmenopausal breast cancer, but new data suggest that these agents may play a role in reducing recurrent breast cancer as well.
Theresa Guise, M.D., professor of medicine and Jerry W. and Peg S. Throgmartin professor of oncology in the Division of Endocrinology at the Indiana University School of Medicine, will m . . .